AGP Executive Report
Last update: 9 hours agoMiCA Deadline Looms for Crypto Firms: With the EU’s MiCA transition ending July 1, Liechtenstein and other EEA-based providers face a hard stop: only 244 of 3,000+ previously registered crypto firms secured MiCA authorisation, and estimates suggest up to 80% may not survive the switch as licensing and capital locks bite. Sygnum Expansion from Liechtenstein: In contrast, Swiss digital asset bank Sygnum says its Liechtenstein subsidiary has won a MiCA licence, giving it direct EU/EEA access and a push into private wealth and institutions. Healthcare Cross-Border Rules: A guide explains how EU cross-border healthcare works in practice—when prior authorisation applies, what costs are covered, and how patients claim—highlighting the legal and administrative friction behind “medical freedom.” Rett Treatment Clears EU Hurdle: Neuren’s DAYBU (trofinetide) gained a positive CHMP opinion for EU marketing, with Acadia’s partner pathway now awaiting the European Commission decision. Trade & Compliance Watch: The UK’s new consolidated dual-use export licence aims to cut paperwork while keeping controls tight, and Brussels is reportedly weighing broader anti-subsidy tariffs for Chinese plug-in hybrids.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
.jpg/r%5Bwidth%5D=1280/4d5a76f0-708d-11f1-be16-91dfdbc3dd29-Greg%20Lang_RAIN_Shutterstock.com_1835304859Yaoinlove%20(2).jpg)
